Genetic and oncogenic features of RASGRF fusions
Sreya Das(Yale Cancer Center), Frederick H. Wilson(Yale Cancer Center)
Cited by 2
Related Papers
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition
|npj Precision Oncology|2024|4